Curriculum · Mental Health / Psychiatry
Opioid overdose and its reversal
What it is
Opioid overdose is defined on the management algorithm by a respiratory rate under 12 breaths per minute when the patient is not asleep. Opioid toxicity is a clinical diagnosis. Naloxone is a short acting opioid antagonist, indicated for the reversal of the respiratory depression associated with narcotic overdoses. It is an effective antagonist for all opiates and many synthetic opioid compounds, and it is ineffective in reversing coma due to any other cause.
How it presents
Pinpoint pupils with a low respiratory rate in a comatose patient is the combination that prompts a trial of naloxone. Bradycardia may be seen on the ECG. The blood gas shows the respiratory failure: a venous gas with a pH of 7, a PaCO2 of 82, a PaO2 of 20 and a lactate of 7 is the kind of result produced.
How it is diagnosed
The diagnosis is clinical. On the algorithm for the patient with an altered mental status, once intravenous glucose has been given and has not improved matters, you ask whether the pupils are pinpoint, what the history is, what urine toxicology screening shows, and whether there is improvement after naloxone; a yes leads to opioids poisoning and ED observation. After resuscitation is initiated the investigations are a urine drug screen, an ECG for bradycardia, CT head, RFT, CK, a repeat blood gas to see the response to treatment, and a CXR. Co-ingestion is looked for, aspirin and paracetamol in particular.
How it is treated
- ABCDE and adequate ventilation come first: support respiration with a bag-valve mask before administering naloxone.
- The coma cocktail is oxygen, 50 ml of 50% dextrose, naloxone and thiamine. For a diminished level of consciousness the order given is 50 mL of 50% dextrose in adults and 1 mL/kg for children by the intravenous route, then naloxone, then thiamine 100 mg IV.
- The pages do not agree on the first dose. One dosing algorithm starts at an initial adult dose of 0.04 mg and an initial pediatric dose of 0.1 mg/kg of body weight, then escalates to 0.5 mg, 2 mg, 4 mg, 10 mg and 15 mg if an increase in respiratory rate does not occur in 2-3 min. A summary page gives 0.05 mg for a spontaneously breathing patient and 0.2-1mg for an apneic patient, and 0.8 to 2.0 mg IV for a diminished level of consciousness, repeated in 1 to 2 mg bolus every 2 to 3 minutes up to 8 to 10 mg. The altered mental status algorithm prescribes 0.8-2 mg IV.
- The dose is adjusted to reverse respiratory depression while avoiding effects of opioid withdrawal, and escalating doses are given until respiratory effort is restored. It is repeated because the half life of narcotics is longer than that of naloxone, which is 60min.
- Naloxone is dispensed as an injectable solution in doses of 0.4 mg per milliliter and 1 mg per milliliter for adults and is almost devoid of adverse effects. Children up to the age of about 5 years or a body weight of up to 20 kg frequently require larger doses, because the ingested dose per kilogram of body weight is relatively higher.
- The long-acting opioid question is asked twice, once on each arm of the tree, and the two arms do not answer alike. Where the respiratory rate is under 12, methadone, a fentanyl patch or another long-acting or extended release opioid analgesic sends the patient to the intensive care unit, and a no means observation for 4-6 hr after the last naloxone dose. Where the rate is not under 12, the same drugs mean observation for a minimum of 8 hr, and a no again means 4-6 hr after the last naloxone dose.
- The next question is whether the patient is awake and alert in the absence of oral or tactile stimuli. A no admits to the intensive care unit, and a continuous naloxone infusion is started or orotracheal intubation performed for recurrent respiratory depression. Continue therapy until the patient has normal respiratory effort and normal mental status, observe for 4-6 hr after the naloxone infusion is stopped, and consider discharge when the patient is awake and alert with normal vital signs.
- Naloxone treats the overdose and is not the treatment of opioid use disorder. Buprenorphine is used for that, with clonidine 0.1-0.3 mg every 6-8 hours as a useful adjunct to increase the rates of abstinence and decrease stress-related opioid cravings. Methadone and naltrexone also treat opioid use disorder, but neither would be used simultaneously with buprenorphine.